Dong-Su Kim

9PUBLICATIONS
10CO-AUTHORS
Biologically active moleculesGene and molecular therapyMedical molecular engineering of nucleic acids and proteinsBiomedical imagingHealth and ecological risk assessment
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jul 14, 2026
Synthesis of Nitazoxanide Derivatives as Potent and Orally Available HBx-DDB1 Inhibitors against Hepatitis B Virus.

|Jun 18, 2026
Development and Biological Evaluation of a GLUT-Inhibiting Theranostic Agent, MF48, for Colorectal Cancer Therapy.

|Mar 21, 2024
Correction to "Discovery and Feasibility Study of Medical Fluorophore 33 as a Novel Theranostic Agent".

Kwang Hee Son, Da Sol Lee, Geumi Park

|Sep 15, 2023
Discovery and Feasibility Study of Medical Fluorophore 33 as a Novel Theranostic Agent.

Kwang Hee Son, Da Sol Lee, Geumi Park

|Dec 01, 2021
Discovery of novel phenaleno isoquinolinium-based fluorescence imaging agents for sentinel lymph node mapping.

Ye Ri Han, Da-Sol Lee, Sang Bong Lee

|Nov 05, 2019
Medical fluorophore 1 (MF1), a benzoquinolizinium-based fluorescent dye, as an inflammation imaging agent.

Sang Bong Lee, Ye Ri Han, Hui-Jeon Jeon

Pageof 2

Frequent Collaborators

6 joint publications

Yong Hyun Jeon

3 joint publications

Chul-Ho Jun

2 joint publications

Jungwook Chin

2 joint publications

Ye Ri Han